Chief Business Officer
Scott Greenberg brings to the company a wealth of experience across a number of functional disciplines garnered at Roivant Sciences and Celgene Corporation. Scott most recently served as Vice President, Head of Operations at Roivant Sciences, where he was responsible for executive direction of newly established clinical-stage companies. Prior to Roivant, he spent more than a decade at Celgene Corporation (now BMS/Celgene) in multiple roles spanning business development, alliance management, operations, R&D project leadership, sales and marketing. He began his career in investment banking at Goldman Sachs & Co. Scott has a dual degree, with a BS in Economics and a BA in Biological Basis of Behavior with a minor in Mathematics, from the University of Pennsylvania as well as an MBA from Harvard Business School.